Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Start your free trial now

Instant access. No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: ALINIA

« Back to Dashboard
Alinia is a drug marketed by Romark and is included in two NDAs. It is available from two suppliers. There are five patents protecting this drug.

This drug has one hundred and twenty-one patent family members in forty-two countries.

The generic ingredient in ALINIA is nitazoxanide. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the nitazoxanide profile page.

Summary for Tradename: ALINIA

Patents:5
Applicants:1
NDAs:2
Suppliers / Packagers: see list5

Pharmacology for Tradename: ALINIA

Drug ClassAntiprotozoal

Clinical Trials for: ALINIA

Study of the Impact of Nitazoxanide on Chronic Hepatitis Patients
Status: Completed Condition: Hepatitis C

Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection
Status: Active, not recruiting Condition: HCV Coinfection; HIV Infection

The Effects of Nitazoxanide in Hepatic Encephalopathy
Status: Recruiting Condition: Hepatic Encephalopathy

Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
Status: Completed Condition: Influenza

Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C
Status: Completed Condition: Chronic Hepatitis C

4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis C
Status: Completed Condition: Chronic Hepatitis C

Nitazoxanide for the Treatment of Prolonged Diarrhea in Children
Status: Completed Condition: Diarrhea

Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children
Status: Completed Condition: Rotavirus Infection; Viral Gastroenteritis Due to Rotavirus

Finding Better Treatment of Bronchiolitis: A Clinical Trial of Oral Nitazoxanide for the Treatment of Bronchiolitis in Infants Presenting to Hospital Emergency Departments
Status: Not yet recruiting Condition: Bronchiolitis

Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
Status: Completed Condition: Influenza

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002RXYes5,578,621<disabled><disabled>
Romark
ALINIA
nitazoxanide
TABLET;ORAL021497-001Jul 21, 2004RXYes6,020,353<disabled>YY<disabled>
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002RXYes5,968,961<disabled><disabled>
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002RXYes5,965,590<disabled><disabled>
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002RXYes6,117,894<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: ALINIA

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,886,013 Antiviral composition<disabled in preview>
5,387,598 Composition and galenic formulation suitable for combatting affections of the lower abdomen<disabled in preview>
6,051,576 Means to achieve sustained release of synergistic drugs by conjugation<disabled in preview>
5,859,038 Method for treatment of helicobacter pylori infections<disabled in preview>
5,856,348 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: ALINIA

Country Document Number Publication Date
Estonia04870Aug 15, 2007
Poland193275Jan 31, 2007
European Patent Office1005342Jun 07, 2000
Israel132516Dec 10, 2003
African Intellectual Property Organization (OAPI)10463Apr 03, 2002
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc